ENLIVEN THERAPEUTICS
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives. The company's discovery process combines clinically validated biological targets and industry-leading chemistry to address the limitations of existing therapies. This approach allows us to ef๏ฌciently and effectively develop precision oncology therapeutics that enhance overall patient well-being. Founded in July 2019 by Sam Kintz, MBA, Joe Lyssikatos, PhD, and Anish Patel, PharmD, Enliven Therapeutics is based in Boulder, Colorado.
ENLIVEN THERAPEUTICS
Social Links:
Industry:
Biotechnology Life Science Therapeutics
Founded:
2019-01-01
Address:
Boulder, Colorado, United States
Country:
United States
Website Url:
http://www.enliventherapeutics.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
140 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Apache Global Site Tag
Similar Organizations
Affinia Therapeutics
Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with devastating diseases.
ALX Oncology
ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
Alloy Therapeutics
Alloy Therapeutics is a biotech company that makes medicine by democratizing access to foundational drug discovery platforms and services.
Altay Therapeutics
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for chronic inflammatory conditions.
Black Diamond Therapeutics
Black Diamond Therapeutics is a precision oncology medicine company pioneering the discovery and development of small molecule.
Calithera Biosciences
Calithera Biosciences is a pharmaceutical company developing novel small molecule therapeutics for the treatment of cancer.
Galera Therapeutics
Galera Therapeutics develops therapeutic agents for preventing damage to normal tissues during the radiation treatment of cancer.
Gallant Pet
Gallant Pet is a pet service company that develops a stem cell therapy intended for dog wounds.
ImmPACT Bio
ImmPACT Bio USA is developing novel cell therapies for treating cancer.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Kanaph Therapeutics
Kanaph Therapeutics is a leading biotech in oncology, auto-immune, and eye diseases with large molecules and small molecules.
MDI Therapeutics
MDI Therapeutics is a operator of an discovery stage company focused on developing novel therapies for fibrotic diseases.
Mitobridge
Mitobridge is discovering and developing small molecule therapeutics that improve mitochondrial functions.
NeuroNascent
Neuronascent discovers and develops small molecule therapeutics for depression and neurodegenerative diseases.
Phoenicis
Phoenicis focuses on developing therapies to provide hope and relief to people living with rare disease.
Restore Vision
Restore Vision is a biotechnology company developing a visual restoration gene therapy for retinitis pigmentosa.
Scorpion Therapeutics
Scorpion Therapeutics is a precision oncology company that broadens the reach and impact of precision medicine for cancer patients.
Signum Biosciences
Signum Biosciences develops small molecule therapeutics derived from its STM platform to modulate signal transduction imbalances.
SiteOne Therapeutics
SiteOne Therapeutics is a San Francisco-based company that develops novel therapeutics and diagnostics.
Strand Therapeutics
Strand Therapeutics is a developer of a biotechnology platform intended to create gene therapies powered by synthetic biology.
Synnovation Therapeutics
Synnovation Therapeutics is a precision oncology company that develops therapeutics that can improve the lives of people with cancer.
SyntheX
SyntheX is a biotechnology firm developing highly specific drugs for previously undruggable targets to treat cancer and rare diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Surveyor Capital
Surveyor Capital investment in Series B - Enliven Therapeutics
Cormorant Asset Management
Cormorant Asset Management investment in Series B - Enliven Therapeutics
Boxer Capital
Boxer Capital investment in Series B - Enliven Therapeutics
Janus Henderson Investors
Janus Henderson Investors investment in Series B - Enliven Therapeutics
Logos Capital
Logos Capital investment in Series B - Enliven Therapeutics
OrbiMed
OrbiMed investment in Series A - Enliven Therapeutics
Roche Venture Fund
Roche Venture Fund investment in Series A - Enliven Therapeutics
5AM Ventures
5AM Ventures investment in Series A - Enliven Therapeutics
OrbiMed
OrbiMed investment in Seed Round - Enliven Therapeutics
5AM Ventures
5AM Ventures investment in Seed Round - Enliven Therapeutics
Official Site Inspections
http://www.enliventherapeutics.com Semrush global rank: 9.7 M Semrush visits lastest month: 114
- Host name: ec2-34-192-255-123.compute-1.amazonaws.com
- IP address: 34.192.255.123
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
